Biotechnology · Burlington, MA · Founded 2017 · Privately Held (backing)
Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. Cardurion is based in Burlington, MA and was founded in 2017. Its last known valuation is $760 million. It has raised $622 million across 1 recorded round; the latest was a $260 million Series B in Jul 2024.
Last price · $/share
—
Implied valuation
$760.0M
Total raised
$621.8M
Last round
Later Stage VC (Series B)
Jul 2024
Team — not yet on record
No current team members for Cardurion are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cardurion with a free account
·The complete investor list: 16 names
·Watch Cardurion: the Monday email on marks, rounds and moves
